SUMMARY The serum concentrations of zinc and copper were measured in 50 patients with multiple sclerosis. Lower serum zinc levels were found compared to age-and sex-matched controls. In younger patients low serum copper concentrations were noted. Zinc concentrations in CSF were unchanged. The possibility that malabsorption of the metals causes the low serum concentrations is discussed.
Patients
Serum was collected from 50 patients with clinically definite multiple sclerosis according to the criteria of McDonald and Halliday. 22 Patients from a neurological ward and a rehabilitation centre, as well as outpatients, were included in the study over three years. Twenty-one were males, median age 34 years (range , and 29 females, median age 39 years (range 23-76). The median age for the first symptoms of the disease was 26 years (range 14-52) for the males and 29 (range 15-41) for the females. None of the patients were on ACTH, corticosteroid, oestrogen, oral contraceptive or phenytoin therapy, all of which may alter the serum concentrations of Zn and Cu. Blood Hb was more than 115 g/l and ESR less than 25 mm/h in all patients. None of the women was pregnant. No clinical or laboratory signs of acute or chronic infection, malnutrition, liver disease or pressure sores were observed. From 29 of the patients, 11 males and 18 females, CSF samples also were obtained.
Age and sex matched control serum samples were selected from a pool of 75 healthy volunteers from the same geographical area as the patients. They were taking no drugs, including oral contraceptives, and they had no clinical or laboratory signs of infection, anaemia or liver disease. None of the women was pregnant. Age-and sexmatched controls for the patients who provided CSF samples were taken from a pool of 52 CSF samples assumed to be normal. Eighteen came from healthy volunteers23 and the remainder from patients with psychoneurosis, tension headache and other pain syndromes in whom neurological examination failed to define an organic CNS lesion. All had macroscopically clear CSF with a leucocyte count of less than 5/,l, and a CSF protein concentration of less than 500 mg/I.
Clinical parameters
The stage of disease at the time of sampling was described as (a) acute exacerbation if the symptoms had started within the previous ten days, or (b) remission or steady state if new symptoms were older than ten days, had com-pletely or partially disappeared or if the disease was in "steady state", or as (c) slowly progressive disease. Duration, disability levels and degree of malignancy of disease were registered and scored according to Johnson et al. 24 The duration of the disease was scored as 5 when it was 1-3 years, 4 when it was 4-6 years, 3 when it was 7-9 years, 2 when it was 10-15 years, and 1 when it was >15 years. The 14-3 + 1-6 11-6 ± 2-3 13-0 + 1-8 Cu 15-2 + 4-2 14-9 ± 1-8 16-1 + 2-9
17-1 ± 2-2 Albumin 41 ± 3 43 ± 4 40 ± 4 40 ± 3 9- 20 Mean age 30 + 6 (n = 8) 31 4-2 ± 1-2 * -p < 0-05 serum Cu concentrations. The males with moderate or severe disability and a duration of more than six years had lower serum Zn concentrations than the controls. Lower serum albumin levels were found in males with mild disability and in females with severe disability. Degree of malignancy (table 6) Lower serum Zn concentrations were found in males with a low score (less than 9). 7 and 8, fig 3) Slightly lower CSF Zn, CSF protein and CSF albumin concentrations and CSF/serum albumin ratio were found in the males with multiple sclerosis compared with the controls. In the females with multiple sclerosis these parameters were CSF Zn-CSF/serum alb. with the lower plasma Zn levels reported by Wong et al." Their study is the only one which has reported low plasma Zn levels in multiple sclerosis. They did not find any apparent relationship between the plasma Zn concentration and the clinical classification of the disease. The decreases in plasma Zn levels was related to age; lower plasma Zn levels were found under the age of 50 years. No difference in plasma Zn concentrations between males and females was found in the patients or controls. The depressed serum Zn levels noted in the present study are in contrast to the reports by Dore-Duffy et al,10 who reported increased plasma Zn levels in 50 patients with multiple sclerosis.
CSF-ANALYSIS (tables
The female patients in the present study had a less pronounced depression of the serum Zn level than the males. One explanation may be that most female patients and controls were in the fertile age, and variation of the serum Zn level is seen during the menstrual cycle. 36 The lower serum Zn concentrations found in the younger males is in accordance with earlier reports. " The unchanged serum Cu concentration in the group of patients with multiple sclerosis is in accordance with most other reports. [13] [14] [15] [16] The patients, however, had more variable concentrations than the controls, as has been reported by Plum and Hansen.'s Depressed serum Cu levels, however, were found in younger patients of both sexes in the present study.
Earlier reports of serum or plasma concentrations of Zn and Cu in multiple sclerosis have been discordant. Non-standardised blood sampling, contamination problems and the lack of age and sex matched controls may account for the differences.
A probable that low serum Zn concentrations in the patients reflect an albumin deficiency. The CSF Zn levels measured by our method were considerably lower than in previous reports. 23 Slightly lower CSF Zn levels were found in the males with multiple sclerosis compared to the controls. The low CSF Zn levels may reflect a zinc deficiency in the CNS. Significant correlations were found between the CSF concentrations of Zn, protein and albumin and the CSF/serum albumin ratio in the controls. The latter ratio is considered to be a good test of the blood-brain barrier function.45 The lack of correlations in the patients with multiple sclerosis was unexpected and may indicate a changed zinc metabolism within the CNS. The importance of the low serum Zn concentrations in patients with multiple sclerosis is still unknown. The decrease in serum Zn, the lack of correlation between serum Zn and age in the male patients, the lack of correlation between CSF Zn and protein parameters in CSF indicate that some changes in zinc metabolism does occur in patients with multiple sclerosis.
Mickel" has presented the following speculative hypothesis to explain the aetiology of multiple sclerosis. An enteric inflammation increases the absorption of lipid peroxides and these peroxides initiate a chain reaction propagation resulting in peroxidative attacks on poly-unsaturated fatty acids such as arachidonic acid in the platelets. Enhanced platelet aggregation occurs with release of peroxidised lipid and subsequent damage to endothelial cells and oligodendroglial cells. Zinc inhibits lipid peroxidation in vivo as well as in vitro.4 It is conceivable that zinc deficiency could increase the postulated peroxidative damage in multiple sclerosis. The value of zinc therapy in slowing or stopping the progress of multiple sclerosis might be worth evaluating.
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